New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 25, 2013
09:19 EDTELNElan acknowledges 'heavily conditional" Royalty Pharma acquisition proposal
The Board of Elan Corporation acknowledges this morning's announcement by Royalty Management regarding an indicative, conditional, proposal which may or may not lead to an offer being made for the entire issued share capital of the company. As previously announced, in anticipation of executing and closing the recently announced Tysabri transaction, the company's Board of Directors, Executive Management and advisors have been working for over a year on a number of strategic transactions that, should they be consummated, would be to the benefit of our public shareholders. Returning capital through share repurchase, diversifying business and asset risk/reward through non-traditional business structures while simultaneously capturing the long term high margin royalty income from Tysabri will offer a compelling investment thesis for our current shareholders. The company notes the highly opportunistic timing of the announcement by Royalty Pharma - a privately held investment management company - before the company’s shareholders have had the opportunity to assess and realize the full benefit of the Tysabri transaction and the partial unlocking of its value. We expect the Tysabri transaction to close in the near future. The company also notes the heavily conditional nature of this indication of interest.
News For ELN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for ELN

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use